Report cover image

Microchips in Medicine Market: Current Analysis and Forecast (2022-2028)

Publisher UnivDatos Market Insights
Published Feb 01, 2023
Length 137 Pages
SKU # Univ17823843

Description

Microchips in Medicine Market: Current Analysis and Forecast (2022-2028)

Medical implant makers incorporate chemicals or medications with the purpose of increasing efficacy and morbidity. Microchips are a novel technology that enables the on-demand delivery of diverse medications over long durations using several reservoirs with discrete pharmacological doses. The global microchips in medicine market is growing at a tremendous rate owing to rising life-threatening diseases, such as specific types of cancers, neurological disorders, and pediatric and rare diseases. For instance, according to the data published by the American Cancer Society (ACS), in January 2020, around 1.8 million new cancer cases were diagnosed and 606,520 cancer deaths in the United States

The microchips in medicine market is expected to grow at a steady rate of around 11% owing to the increasing growing investment and clinical trials of these medicines. Furthermore, growing technological advancements in microchips in medicine technology is expected to significantly influence the market growth over the forecast period.
  • Based on application, the market is segmented into drug delivery, home monitoring, and others. Among them, the drug delivery category is to witness higher CAGR during the forecast period owing to the growing demand for enhanced drug delivery systems, which have advantages such as improving the consumption of active pharmaceutical ingredients, reducing dosage frequency, and minimizing adverse/side effects which will further drive the growth of the segment.
  • On the basis of end-user, the market is categorized into hospitals, research centers, and others. Among these, the hospital held a significant share of the market in 2020. This is mainly due to rising patient administration in hospitals with various neurological diseases, chronic diseases, and rare disorders boosting segmental growth. For instance, according to the Brain Aneurysms Foundation, about 30,000 people in the United States suffer a brain aneurysm rupture each year.
  • For a better understanding of the market adoption of the microchips in medicine industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is anticipated to grow at a substantial CAGR during the forecast period. owing to the continuous technological developments by key players, high investment in R&D, availability of technologically advanced healthcare infrastructure, rising need for technology in medicine development for diagnosis purposes, and the presence of several government initiatives in the U.S. and Canada support research in drug development and treatment of various life-threatening diseases.
  • Some of the major players operating in the market include INTROMEDIC; Otsuka America Pharmaceutical, Inc.; Applied Microarrays, LLC; QIAGEN; Agilent Technologies, Inc.; Medtronic; Illumina, Inc.; BGI; Macrogen, Inc.; Bio-Rad Laboratories, Inc.

Table of Contents

137 Pages
1 MARKET INTRODUCTION
1.1. Market Definitions
1.2. Main Objective
1.3. Stakeholders
1.4. Limitation
2 RESEARCH METHODOLOGY OR ASSUMPTION
2.1. Research Process of the Microchips in Medicine Market
2.2. Research Methodology of the Microchips in Medicine Market
2.3. Respondent Profile
3 MARKET SYNOPSIS
4 EXECUTIVE SUMMARY
5 IMPACT OF COVID-19 ON THE MICROCHIPS IN MEDICINE MARKET
6 MICROCHIPS IN MEDICINE MARKET REVENUE, 2020-2028F
7 MARKET INSIGHTS BY APPLICATION
7.1. Drug Delivery
7.2. Home Monitoring
7.3. Others
8 MARKET INSIGHTS BY TYPE
8.1. Hospital
8.2. Research Centers
8.3. Others
9 MARKET INSIGHTS BY REGION
9.1. North America
9.1.1. U.S.
9.1.2. Canada
9.1.3. Rest of North America
9.2. Europe
9.2.1. Germany
9.2.2. U.K.
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. Rest of Asia-Pacific
9.4. Rest of World
10 MICROCHIPS IN MEDICINE MARKET DYNAMICS
10.1. Market Drivers
10.2. Market Challenges
10.3. Impact Analysis
11 MICROCHIPS IN MEDICINE MARKET OPPORTUNITIES
12 MICROCHIPS IN MEDICINE MARKET TRENDS
13 DEMAND AND SUPPLY-SIDE ANALYSIS
13.1. Demand Side Analysis
13.2. Supply Side Analysis
14 VALUE CHAIN ANALYSIS
15 PRICING ANALYSIS
16 STRATEGIC INSIGHTS
17 COMPETITIVE SCENARIO
17.1. Competitive Landscape
17.1.1. Porters Fiver Forces Analysis
18 COMPANY PROFILED
18.1. INTROMEDIC
18.2. Otsuka America Pharmaceutical, Inc.
18.3. Applied Microarrays, LLC
18.4. QIAGEN
18.5. Agilent Technologies, Inc.
18.6. Medtronic
18.7. Illumina, Inc.
18.8. BGI
18.9. Macrogen, Inc.
18.10. Bio-Rad Laboratories, Inc.
19 DISCLAIMER

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us